Get A$10 trading credit to start you off
Sign up and fund a new Stake AUS account and get A$10 bonus trading credit.Sign up and fund a new Stake AUS account and enjoy an extra A$10 trading credit on us.T&Cs apply
Sign up and fund a new Stake AUS account and get A$10 bonus trading credit.Sign up and fund a new Stake AUS account and enjoy an extra A$10 trading credit on us.T&Cs apply
Botanix Pharmaceuticals Limited (BOT) is a dermatology company headquartered in Philadelphia and Phoenix (US). The company has received FDA approval for its lead product, Sofdra, for the treatment of primary axillary hyperhidrosis. Sofdra is the first and only new chemical entity approved by the FDA for this condition, offering a novel solution that combines safety and effectiveness for patients who previously lacked treatment options for this socially challenging medical disorder.
Find out what a historical investment in Botanix Pharmaceuticals Ltd would be worth today using our BOT stock calculator.
Market Capitalisation
$74M
Price-earnings ratio
-0.58
Dividend yield
-
High today
$0.03
Low today
$0.02
Open price
$0.03
52-week high
$0.40
52-week low
$0.02
Ready to start your investing journey with Stake?
Open an accountThis is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.

Invest in BOT on Stake
Stock shown for demonstrative purposes only. A$3 brokerage up to A$30,000.
BOT related stocks